Shanghai Junshi Biosciences : CHANGE IN CHAIRMAN OF NOMINATION COMMITTEE

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

SHANGHAI JUNSHI BIOSCIENCES CO., LTD.*

上 海 君 實 生 物 醫 藥 科 技 股 份 有 限 公 司

(a joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 1877)

CHANGE IN CHAIRMAN OF NOMINATION COMMITTEE

The board of directors (the "Board") of Shanghai Junshi Biosciences Co., Ltd.* (上海君實生物醫 藥科技股份有限公司) (the "Company") hereby announces with effect from 21 November 2019, the chairman of the nomination committee of the Board (the "Nomination Committee") will be

changed from Mr. Xiong Jun to Mr. Chen Xinjun. The members of the Nomination Committee, being Mr. Xiong Jun, Mr. Qian Zhi and Mr. Chen Xinjun, shall remain unchanged.

By order of the Board of

Shanghai Junshi Biosciences Co., Ltd.*

Mr. Xiong Jun

Chairman

Shanghai, the PRC, 21 November 2019

As at the date of this announcement, the board of directors of the Company comprises Mr. Xiong Jun, Dr. Li Ning, Dr. Feng Hui, Mr. Zhang Zhuobing, Dr. Wu Hai and Dr. Yao Sheng as executive Directors; Mr. Tang Yi, Mr. Li Cong, Mr. Yi Qingqing and Mr. Lin Lijun as non-executive Directors; and Dr. Chen Lieping, Dr. He Jia, Mr. Chen Xinjun, Mr. Qian Zhi and Dr. Roy Steven Herbst as independent non-executive Directors.

• For identification purpose only